Skip to main content
Top
Published in: Sleep and Breathing 3/2014

01-09-2014 | Original Article

Salivary markers of oxidative stress in patients with obstructive sleep apnea treated with continuous positive airway pressure

Authors: L’ubomíra Tóthová, Július Hodosy, Imrich Mucska, Peter Celec

Published in: Sleep and Breathing | Issue 3/2014

Login to get access

Abstract

Purpose

Obstructive sleep apnea syndrome (OSAS) is characterized by elevated oxidative stress. Measurement of oxidative stress in saliva seems to be promising in long-term treatment monitoring of OSAS patients. In this study, our aim was to investigate whether short-term continuous positive airway pressure (CPAP) treatment would influence oxidative stress in saliva.

Methods

Patients with diagnosed OSAS (16 women, 28 men) underwent polysomnography during the first night and CPAP treatment during the second night. Saliva samples were taken in the evening and morning on both days. Markers of oxidative stress and antioxidant status were analyzed in saliva.

Results

Evening concentrations of the salivary thiobarbituric acid reacting substances (p < 0.001), advanced glycation end-products (p < 0.001), and advanced oxidation protein products (p < 0.01) were significantly lower than morning values during the diagnostic night. However, salivary concentrations of none of the oxidative stress markers were significantly influenced by the CPAP treatment. No changes in salivary antioxidant status after CPAP therapy were found.

Conclusion

Salivary markers of oxidative stress and antioxidant status do not change significantly after one night treatment with CPAP. On the contrary, after 1 month with CPAP therapy, reduced markers of oxidative stress were reported. Therefore, the future studies should be focused on finding the optimal sampling frequency to clarify the potential of saliva for the monitoring of OSAS treatment.
Literature
1.
go back to reference Mirrakhimov AE, Sooronbaev T, Mirrakhimov EM (2013) Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature. BMC Pulm Med 13:10PubMedCentralPubMedCrossRef Mirrakhimov AE, Sooronbaev T, Mirrakhimov EM (2013) Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature. BMC Pulm Med 13:10PubMedCentralPubMedCrossRef
3.
go back to reference Parish JM, Adam T, Facchiano L (2007) Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 3:467–472PubMedCentralPubMed Parish JM, Adam T, Facchiano L (2007) Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 3:467–472PubMedCentralPubMed
5.
go back to reference Gharibeh T, Mehra R (2010) Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options. Nat Sci Sleep 2:233–255PubMedCentralPubMed Gharibeh T, Mehra R (2010) Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options. Nat Sci Sleep 2:233–255PubMedCentralPubMed
6.
go back to reference Jurkovicova I, Celec P, Mucska I, Hodosy J (2003) On the origin of cardiovascular complications of sleep apnea syndrome by the means of molecular interactions. Bratisl Lek Listy 104:167–173PubMed Jurkovicova I, Celec P, Mucska I, Hodosy J (2003) On the origin of cardiovascular complications of sleep apnea syndrome by the means of molecular interactions. Bratisl Lek Listy 104:167–173PubMed
8.
go back to reference Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51PubMedCrossRef Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51PubMedCrossRef
9.
go back to reference Zhang J, Veasey S (2012) Making sense of oxidative stress in obstructive sleep apnea: mediator or distracter? Front Neurol 3:179PubMedCentralPubMed Zhang J, Veasey S (2012) Making sense of oxidative stress in obstructive sleep apnea: mediator or distracter? Front Neurol 3:179PubMedCentralPubMed
10.
go back to reference Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123–128PubMed Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123–128PubMed
11.
go back to reference Mancuso M, Bonanni E, LoGerfo A, Orsucci D, Maestri M, Chico L, DiCoscio E, Fabbrini M, Siciliano G, Murri L (2012) Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med 13:632–636PubMedCrossRef Mancuso M, Bonanni E, LoGerfo A, Orsucci D, Maestri M, Chico L, DiCoscio E, Fabbrini M, Siciliano G, Murri L (2012) Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med 13:632–636PubMedCrossRef
12.
go back to reference Ntalapascha M, Makris D, Kyparos A, Tsilioni I, Kostikas K, Gourgoulianis K, Kouretas D, Zakynthinos E (2013) Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath 17:549–555PubMedCrossRef Ntalapascha M, Makris D, Kyparos A, Tsilioni I, Kostikas K, Gourgoulianis K, Kouretas D, Zakynthinos E (2013) Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath 17:549–555PubMedCrossRef
13.
14.
go back to reference Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H, Naseem J, Asif ABawaadam H (2013) Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers—a meta-analysis. J Inflamm (Lond) 10:13CrossRef Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H, Naseem J, Asif ABawaadam H (2013) Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers—a meta-analysis. J Inflamm (Lond) 10:13CrossRef
15.
go back to reference Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, O'Donnell CP, Adachi M (2006) Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 28:378–385PubMedCrossRef Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, O'Donnell CP, Adachi M (2006) Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 28:378–385PubMedCrossRef
16.
go back to reference Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI (2009) Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 10:87–94PubMedCrossRef Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI (2009) Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 10:87–94PubMedCrossRef
17.
go back to reference Singh TD, Patial K, Vijayan VK, Ravi K (2009) Oxidative stress and obstructive sleep apnoea syndrome. Indian J Chest Dis Allied Sci 51:217–224PubMed Singh TD, Patial K, Vijayan VK, Ravi K (2009) Oxidative stress and obstructive sleep apnoea syndrome. Indian J Chest Dis Allied Sci 51:217–224PubMed
18.
go back to reference Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, Somers VK (2005) Oxidative stress in obstructive sleep apnoea. Eur Heart J 26:2435–2439PubMedCrossRef Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, Somers VK (2005) Oxidative stress in obstructive sleep apnoea. Eur Heart J 26:2435–2439PubMedCrossRef
19.
go back to reference Kamodyova N, Celec P (2011) Salivary markers of oxidative stress and Salivette collection systems. Clin Chem Lab Med 49:1887–1890PubMedCrossRef Kamodyova N, Celec P (2011) Salivary markers of oxidative stress and Salivette collection systems. Clin Chem Lab Med 49:1887–1890PubMedCrossRef
20.
go back to reference Celecova V, Kamodyova N, Tothova L, Kudela M, Celec P (2013) Salivary markers of oxidative stress are related to age and oral health in adult non-smokers. J Oral Pathol Med 42:263–266PubMedCrossRef Celecova V, Kamodyova N, Tothova L, Kudela M, Celec P (2013) Salivary markers of oxidative stress are related to age and oral health in adult non-smokers. J Oral Pathol Med 42:263–266PubMedCrossRef
21.
go back to reference Celec P, Hodosy J, Behuliak M, Palffy R, Gardlik R, Halcak L, Mucska I (2012) Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 16:393–398PubMedCrossRef Celec P, Hodosy J, Behuliak M, Palffy R, Gardlik R, Halcak L, Mucska I (2012) Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 16:393–398PubMedCrossRef
22.
go back to reference Alzoghaibi MA, Bahammam AS (2012) The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea. Sleep Breath 16:499–504PubMedCrossRef Alzoghaibi MA, Bahammam AS (2012) The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea. Sleep Breath 16:499–504PubMedCrossRef
23.
go back to reference Tothova L, Ostatnikova D, Sebekova K, Celec P, Hodosy J (2013) Sex differences of oxidative stress markers in young healthy subjects are marker-specific in plasma but not in saliva. Ann Hum Biol 40:175–180PubMedCrossRef Tothova L, Ostatnikova D, Sebekova K, Celec P, Hodosy J (2013) Sex differences of oxidative stress markers in young healthy subjects are marker-specific in plasma but not in saliva. Ann Hum Biol 40:175–180PubMedCrossRef
24.
go back to reference Del Ben M, Fabiani M, Loffredo L, Polimeni L, Carnevale R, Baratta F, Brunori M, Albanese F, Augelletti T, Violi F, Angelico F (2012) Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm Med 12:36PubMedCentralPubMedCrossRef Del Ben M, Fabiani M, Loffredo L, Polimeni L, Carnevale R, Baratta F, Brunori M, Albanese F, Augelletti T, Violi F, Angelico F (2012) Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm Med 12:36PubMedCentralPubMedCrossRef
25.
go back to reference Karamanli H, Ozol D, Ugur KS, Yildirim Z, Armutcu F, Bozkurt BYigitoglu R (2012) Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath. doi: 10.1007/s11325-012-0761-8c Karamanli H, Ozol D, Ugur KS, Yildirim Z, Armutcu F, Bozkurt BYigitoglu R (2012) Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath. doi: 10.1007/s11325-012-0761-8c
27.
go back to reference Sasaki S, Matsuura T, Takahashi R, Iwasa T, Watanabe H, Shirai K, Nakamoto H, Goto S, Akita S, Kobayashi Y (2013) Effects of regular exercise on neutrophil functions, oxidative stress parameters and antibody responses against 4-hydroxy-2-nonenal adducts in middle aged humans. Exerc Immunol Rev 19:60–71PubMed Sasaki S, Matsuura T, Takahashi R, Iwasa T, Watanabe H, Shirai K, Nakamoto H, Goto S, Akita S, Kobayashi Y (2013) Effects of regular exercise on neutrophil functions, oxidative stress parameters and antibody responses against 4-hydroxy-2-nonenal adducts in middle aged humans. Exerc Immunol Rev 19:60–71PubMed
28.
go back to reference Bjelakovic G, Nikolova D, Gluud C (2013) Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin a, and vitamin e singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? PLoS One 8:e74558PubMedCentralPubMedCrossRef Bjelakovic G, Nikolova D, Gluud C (2013) Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin a, and vitamin e singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? PLoS One 8:e74558PubMedCentralPubMedCrossRef
29.
go back to reference Pollanen MT, Paino A, AIhalin R (2013) Environmental stimuli shape biofilm formation and the virulence of periodontal pathogens. Int J Mol Sci 14:17221–17237PubMedCentralPubMedCrossRef Pollanen MT, Paino A, AIhalin R (2013) Environmental stimuli shape biofilm formation and the virulence of periodontal pathogens. Int J Mol Sci 14:17221–17237PubMedCentralPubMedCrossRef
30.
go back to reference Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I, Gavish M, Nagler RM (2009) Salivary analysis of oral cancer biomarkers. Br J Cancer 101:1194–1198PubMedCentralPubMedCrossRef Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I, Gavish M, Nagler RM (2009) Salivary analysis of oral cancer biomarkers. Br J Cancer 101:1194–1198PubMedCentralPubMedCrossRef
31.
go back to reference Vlkova B, Stanko P, Minarik G, Tothova L, Szemes T, Banasova L, Novotnakova D, Hodosy J, Celec P (2012) Salivary markers of oxidative stress in patients with oral premalignant lesions. Arch Oral Biol 57:1651–1656PubMedCrossRef Vlkova B, Stanko P, Minarik G, Tothova L, Szemes T, Banasova L, Novotnakova D, Hodosy J, Celec P (2012) Salivary markers of oxidative stress in patients with oral premalignant lesions. Arch Oral Biol 57:1651–1656PubMedCrossRef
32.
go back to reference Hegde AM, Rai K, Padmanabhan V (2009) Total antioxidant capacity of saliva and its relation with early childhood caries and rampant caries. J Clin Pediatr Dent 33:231–234PubMed Hegde AM, Rai K, Padmanabhan V (2009) Total antioxidant capacity of saliva and its relation with early childhood caries and rampant caries. J Clin Pediatr Dent 33:231–234PubMed
33.
go back to reference Su H, Velly AM, Salah MH, Benarroch M, Trifiro M, Schipper HM, Gornitsky M (2012) Altered redox homeostasis in human diabetes saliva. J Oral Pathol Med 41:235–241PubMedCrossRef Su H, Velly AM, Salah MH, Benarroch M, Trifiro M, Schipper HM, Gornitsky M (2012) Altered redox homeostasis in human diabetes saliva. J Oral Pathol Med 41:235–241PubMedCrossRef
34.
go back to reference Behuliak M, Palffy R, Gardlik R, Hodosy J, Halcak L, Celec P (2009) Variability of thiobarbituric acid reacting substances in saliva. Dis Markers 26:49–53PubMedCentralPubMedCrossRef Behuliak M, Palffy R, Gardlik R, Hodosy J, Halcak L, Celec P (2009) Variability of thiobarbituric acid reacting substances in saliva. Dis Markers 26:49–53PubMedCentralPubMedCrossRef
35.
go back to reference Kamodyova N, Tothova L, Celec P (2013) Salivary markers of oxidative stress and antioxidant status: influence of external factors. Dis Markers 34:313–321PubMedCentralPubMedCrossRef Kamodyova N, Tothova L, Celec P (2013) Salivary markers of oxidative stress and antioxidant status: influence of external factors. Dis Markers 34:313–321PubMedCentralPubMedCrossRef
36.
go back to reference Quintero M, Gonzalez-Martin MD, Vega-Agapito V, Gonzalez C, Obeso A, Farre R, Agapito T, Yubero S (2013) The effects of intermittent hypoxia on redox status, NFkappaB activation, and plasma lipid levels are dependent on the lowest oxygen saturation. Free Radic Biol Med 65:1143–1154 Quintero M, Gonzalez-Martin MD, Vega-Agapito V, Gonzalez C, Obeso A, Farre R, Agapito T, Yubero S (2013) The effects of intermittent hypoxia on redox status, NFkappaB activation, and plasma lipid levels are dependent on the lowest oxygen saturation. Free Radic Biol Med 65:1143–1154
37.
go back to reference Force TRoaAAoSMT (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689 Force TRoaAAoSMT (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689
38.
go back to reference Pendyala G, Thomas B, Joshi SR (2013) Evaluation of total antioxidant capacity of saliva in type 2 diabetic patients with and without periodontal disease: a case–control study. N Am J Med Sci 5:51–57PubMedCentralPubMedCrossRef Pendyala G, Thomas B, Joshi SR (2013) Evaluation of total antioxidant capacity of saliva in type 2 diabetic patients with and without periodontal disease: a case–control study. N Am J Med Sci 5:51–57PubMedCentralPubMedCrossRef
39.
go back to reference Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2002) Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 122:1162–1167PubMedCrossRef Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2002) Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 122:1162–1167PubMedCrossRef
40.
go back to reference Franco CM, Lima AM, Ataide L Jr, Lins OG, Castro CM, Bezerra AA, de Oliveira MF, Oliveira JR (2012) Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms. J Mol Neurosci 47:300–310PubMedCrossRef Franco CM, Lima AM, Ataide L Jr, Lins OG, Castro CM, Bezerra AA, de Oliveira MF, Oliveira JR (2012) Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms. J Mol Neurosci 47:300–310PubMedCrossRef
Metadata
Title
Salivary markers of oxidative stress in patients with obstructive sleep apnea treated with continuous positive airway pressure
Authors
L’ubomíra Tóthová
Július Hodosy
Imrich Mucska
Peter Celec
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 3/2014
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-013-0919-z

Other articles of this Issue 3/2014

Sleep and Breathing 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.